Liraglutide

Liraglutide is a synthetic, acylated analog of human glucagon-like peptide-1 (GLP-1) that acts as a GLP-1 receptor agonist. It is studied in laboratory and clinical research involving GLP-1 receptor signaling, glucose metabolism, insulin-associated pathways, metabolic regulation, and energy homeostasis.

Research involving liraglutide examines glucose-dependent insulin signaling, glucagon-associated pathways, gastrointestinal signaling, and other mechanisms related to metabolic and endocrine biology.

Research Classification: GLP-1 receptor agonist / GLP-1 analog Form: Research peptide Intended Use: Laboratory research

Research Use Only. Not for human or veterinary use. This product is intended solely for qualified laboratory research and analytical applications. It is not intended to diagnose, treat, cure, or prevent any disease.